Hyperglycemia facilitates staphylococcal infection in diabetic skin wounds

Yanchun Quan,Yuping Lai
DOI: https://doi.org/10.1016/j.jdermsci.2017.02.207
IF: 5.408
2017-01-01
Journal of Dermatological Science
Abstract:Staphylococcus aureus (S. aureus) is a major cause of infections in patients with diabetes. However, little is known about how S. aureus inhibits innate defense to infect skin wounds of diabetic patients. Here we demonstrated that in normal patients S. aureus infection increased the expression of interleukin-33 (IL-33) in skin. IL-33, in turns, induced the expression of an antimicrobial protein REG3A in keratinocytes and the release of nitric oxygen (NO) in macrophages to inhibit the growth of S. aureus. In diabetes, hyperglycemia regulated S. aureus SarA to express cysteine protease staphopain B (SspB). Secreted SspB from S. aureus cleaved or degraded interleukin-33, thus inactivating the capacity of IL-33 to induce the production of antimicrobial intermediates including REG 3A. This effect was relevant in vivo as IL-33 was significantly increased in normal mice infected by S. aureus wild-type, but it was under detection in the skin of diabetic mice infected by S. aureus wild-type strain. Moreover, decreased IL-33 was restored in the skin of diabetic mice infected by S. aureus sspB mutant. Taken together, hyperglycemia induces the production of cysteine protease SspB in S. aureus to cleave/degrade IL-33, thus facilitating S. aureus infection in the skin of diabetic patients.
What problem does this paper attempt to address?